Medicare turnaround pulls Centene ahead of schedule
Centene’s profit recovery moved faster than management expected in the third quarter, with the clearest gains coming from Medicare Advantage and prescription drug plans. The insurer now expects its Medicare business to break even in 2026, a full year earlier than its previous timeline, after what executives described as lower spending across senior-focused products. That shift gave the company enough confidence to raise full-year earnings guidance for the third time this year.
The pace of improvement matters because Centene entered 2026 still carrying the aftereffects of the profit squeeze that began in 2024. Rising medical costs had been eroding margins across government-backed coverage, and Centene’s size in Medicaid and the Affordable Care Act exchange market left it especially exposed. By the end of the third quarter, the company was no longer talking about a distant recovery. It was talking about a business that had already begun to rebuild it.
Medical costs stayed high, but reimbursement caught up
Centene posted a medical loss ratio of 92.7% in the quarter, flat year over year and slightly better than analysts expected. In managed care, that ratio is one of the cleanest snapshots of how much premium revenue is being consumed by patient care. A higher figure leaves less room for administrative expense and profit; a lower figure suggests the insurer is keeping more of each premium dollar after claims.
Medicaid remained the most complicated part of the portfolio. Chief executive Sarah London said spending was still elevated because of behavioral health, home health and high-cost drugs, all categories that can rise quickly when enrollees have complex needs. A Florida contract covering children with complex needs also created a temporary cost spike before Centene handed the contract to Molina Healthcare at the start of October. Even so, the business found enough offset from state reimbursement changes to stay on track.
State rate updates in July, along with off-cycle and retroactive pay bumps, helped cover higher medical costs. London also pointed to more recent cost data being used by state actuaries, which better reflects the underlying trend that has been pressuring margins for the past 18 months. In plain terms, reimbursement finally began to track the actual cost of care more closely.
ACA pressure eased as reserves and risk adjustment helped
Centene’s ACA business came in below analyst expectations on medical loss ratio, but management framed the segment as still holding its ground. Higher-acuity members in silver-tier plans continued to moderate, and the company said some of the cost tied to federal program integrity efforts was absorbed through reserves. Those efforts have been removing people from exchange coverage, changing the risk mix inside the block of business and making claims patterns harder to predict.
The insurer also expects support from the ACA risk adjustment mechanism, which transfers funds from plans with healthier enrollees to plans with sicker ones. For insurers with large exchange footprints, that payment system can meaningfully smooth volatility when membership shifts unexpectedly. Centene now expects its ACA business to land at the upper end of its 4.5% to 5% margin target this year, a sign that pricing, reserve management and risk transfers are all moving in the same direction.
One sentence captures the quarter: the exchange book stopped dragging as hard on the company’s overall results.
Medicare became the profit engine in the quarter
The biggest surprise came from Medicare. Drew Asher, the chief financial officer, said seniors in Centene’s Medicare Advantage and prescription drug plans drove lower-than-expected spending, turning the segment into the quarter’s strongest performer. That improvement carries outsized weight because Medicare had previously been a source of concern, not a source of margin support.
Centene now expects the segment to break even in 2026 rather than operate at a loss. The upgrade in outlook fed directly into the company’s higher adjusted earnings per share target of greater than $5.20, up from greater than $4.80. Revenue reached $50.6 billion, up 2% year over year and ahead of analyst estimates, as reimbursement gains offset the loss of members.
Membership, however, continued to shrink. Centene ended the quarter with 25.7 million members, down 8%, or almost 2.3 million people, from a year earlier. The company’s sales and pricing mix have clearly changed as it has tried to repair margins, and the shrinking footprint helps explain why revenue growth remained modest even as profits improved.
Workforce cuts deepen the margin reset
Centene’s balance sheet improved, but the quarter also carried a visible cost from restructuring. The company lost almost 6,000 employees during the period and spent nearly $280 million on severance. Leadership said the reduction reflected layoffs as well as a voluntary separation program launched in June.
The human toll of that cut is immediate, but the strategic logic is equally blunt: lower operating costs should help margins expand further in 2027. The company’s employee count fell from 59,800 in the second quarter to 53,900 in the third, a sharp drop for a payer of Centene’s scale. Management declined to separate the total into layoffs, contract wind-downs and voluntary departures, but the directional effect is obvious. Fewer employees mean less overhead, and less overhead can matter quickly when medical trends are still unstable.
Centene’s chief executives stopped short of issuing specific guidance for 2027, despite repeated questions from analysts. They did, however, lay out the ingredients they expect to help next year: higher ACA prices, continued Medicaid rate increases from states and lower operating costs from the workforce reductions. The company is betting that these pieces will compound rather than offset one another.
2027 remains unspecific, but the pressure points are visible
The next year still carries unresolved risk. Medicaid cost trends remain elevated, especially in behavioral health and home health, and ACA margins can swing when enrollment mix changes or federal policy shifts alter the risk pool. Centene’s experience in Florida also showed how quickly a single contract can distort quarterly performance when membership is concentrated in complex populations.
The broader significance lies in how the recovery is being built: not from a single windfall, but from several narrower improvements happening at once. Better state reimbursement, stronger Medicare performance, higher ACA pricing and lower staffing costs all contributed in the same quarter. If those trends hold, Centene enters 2027 with a cleaner earnings base than it had earlier in the year.
For now, the company’s message is unmistakable. Profit recovery is no longer just a forecast; it is showing up in the numbers, even as membership falls and restructuring costs remain visible on the income statement.